Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Nanjing Medical University
Headquarters: Nanjing, China
Website: http://english.njmu.edu.cn
Year Founded: 1934
Status: Non-biopharma
Biopharma related deals can be found by searching the organization's name in the Deals Module.
BioCentury | Aug 1, 2024
Distillery Therapeutics
Targeting an ALKBH5-IL11 receptor axis for cardiac fibrosis
BioCentury | Oct 27, 2023
Discovery & Translation
BMS’s dual lipid kinase inhibitor; plus prime editing in NHPs and more
BioCentury’s roundup of translational innovation
BioCentury | Aug 23, 2023
Distillery Therapeutics
Engineered oncolytic virus expressing APOA1 for glioblastoma
BioCentury | Aug 2, 2023
Distillery Therapeutics
Inhibiting a circular RNA-encoded MET variant for glioblastoma
BioCentury | Feb 10, 2022
Discovery & Translation
Translational trendspotting: a Distillery dive into neurology
Highlights include a new approach to the amyloid hypothesis, white space strategies for stroke and gene therapies
BioCentury | Aug 27, 2021
Distillery Therapeutics
PROK2-mediated suppression of ferroptosis as a target for traumatic brain injury
Items per page:
1 - 10 of 19